Publicaciones en colaboración con investigadores/as de Centro de Investigación en Red en Enfermedades Cardiovasculares (36)

2022

  1. Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy

    Cells, Vol. 11, Núm. 2

  2. Sex Differences in Low-Density Lipoprotein Cholesterol Reduction with PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

    Journal of Cardiovascular Pharmacology, Vol. 79, Núm. 4, pp. 523-529

2021

  1. Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events

    Journal of cardiovascular pharmacology, Vol. 77, Núm. 2, pp. 164-169

  2. Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer

    European Journal of Clinical Investigation, Vol. 51, Núm. 5

  3. Managing NSTEMI in older patients

    The Lancet

  4. Mortality associated with cardiovascular disease in patients with COVID-19

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38

  5. Neuromodulatory Approaches for Atrial Fibrillation Ablation

    European Cardiology Review , Vol. 16

  6. New-onset heart failure after acute coronary syndrome in patients without heart failure or left ventricular dysfunction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 6, pp. 494-501

  7. Reply to the Editor—Electrophysiologic study in women with Brugada Syndrome

    Heart Rhythm

  8. Selection of the best of 2020 in cardiac arrhythmias

    REC: CardioClinics, Vol. 56, pp. 41-47

  9. Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1741-1753

  10. Updates on epicardial adipose tissue mechanisms on atrial fibrillation

    Obesity Reviews, Vol. 22, Núm. 9

2020

  1. CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure

    Frontiers in Physiology, Vol. 11

  2. Estimation of the major cardiovascular events prevention with Inclisiran

    Atherosclerosis, Vol. 313, pp. 76-80

  3. High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment

    Atherosclerosis, Vol. 292, pp. 60-69

  4. Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open-heart surgery

    Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 18, pp. 10958-10969

  5. Long-term bleeding risk vs. mortality risk in acute coronary syndrome patients according to the 2019 ARC-HBR definition

    Thrombosis Research

  6. Myocardium metabolism in physiological and pathophysiological states: Implications of epicardial adipose tissue and potential therapeutic targets

    International Journal of Molecular Sciences, Vol. 21, Núm. 7

  7. Prevention of myocardial infarction and stroke with PCSK9 inhibitors treatment: a metanalysis of recent randomized clinical trials

    Journal of Diabetes and Metabolic Disorders, Vol. 19, Núm. 2, pp. 759-765

  8. Sex-related differences in long-term mortality and heart failure in a contemporary cohort of patients with NSTEACS. The cardiochus-HSUJ registry

    European Journal of Internal Medicine, Vol. 81, pp. 26-31